Arcutis Biotherapeutics, Inc.
ARQT
$31.10
$1.143.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.13% | -3.67% | -13.10% | -31.04% | -8.79% |
| Total Receivables | 7.90% | 24.91% | 16.90% | 21.54% | 38.49% |
| Inventory | 37.34% | -1.75% | 14.37% | 3.65% | 0.97% |
| Prepaid Expenses | 27.36% | -45.81% | 30.32% | 29.71% | -19.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -6.78% | 36.14% | -5.57% | -16.39% | 203.33% |
| Total Current Assets | 4.94% | 2.81% | -3.62% | -20.74% | -2.50% |
|
|
|||||
| Total Current Assets | 4.94% | 2.81% | -3.62% | -20.74% | -2.50% |
| Net Property, Plant & Equipment | 85.20% | -6.47% | 11.49% | -7.76% | -7.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -3.53% | -3.41% | 74.07% | -3.20% | 61.50% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.17% |
| Total Assets | 5.26% | 2.42% | -1.37% | -20.23% | -1.66% |
|
|
|||||
| Total Accounts Payable | -61.58% | -38.51% | 72.50% | -26.42% | 143.30% |
| Total Accrued Expenses | 5.83% | 33.60% | -0.33% | 24.97% | 23.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 18.76% | 2.68% | -99.18% | 12,810.04% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -4.01% | 14.05% | 12.49% | -53.02% | 235.77% |
|
|
|||||
| Total Current Liabilities | -4.01% | 14.05% | 12.49% | -53.02% | 235.77% |
| Long-Term Debt | 0.42% | -0.53% | 0.39% | 2.01% | -48.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 149.57% | -9.66% | -8.67% | -7.58% | -6.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | -36.84% | 35.71% | 116.49% |
| Total Liabilities | -0.26% | 5.96% | 5.28% | -31.84% | 8.66% |
|
|
|||||
| Common Stock & APIC | 0.90% | 0.94% | 0.81% | 0.96% | 0.87% |
| Retained Earnings | 0.64% | -1.39% | -2.23% | -0.97% | -3.88% |
| Treasury Stock & Other | -77.14% | 75.00% | -1,900.00% | -101.31% | 281.29% |
| Total Common Equity | 13.74% | -2.58% | -9.45% | 0.57% | -15.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.74% | -2.58% | -9.45% | 0.57% | -15.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.74% | -2.58% | -9.45% | 0.57% | -15.98% |
|
|
|||||